RECORD // Company

Integra Lifesciences Holdings Corp

Formerly: INTEGRA LIFESCIENCES CORP

Built 2026-11-21T11:17:53Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Records under a former name (9)

The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.

Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

9 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-23 · accession 0000917520-26-000077

ItemValuePeriodFormFiledAccessionReport
Revenue$411,182,0003 months ended 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Net income (loss)$14,852,0003 months ended 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Interest expense$22,961,0003 months ended 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Cash and cash equivalents$252,261,000at 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Contract liabilities (total)$21,524,000at 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Contract liabilities, current$12,075,000at 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Contract liabilities, noncurrent$9,400,000at 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Debt due in the next 12 months$53,281,000at 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error
Debt due in year 2$634,531,000at 2026-09-3010-Q2026-10-230000917520-26-0000772026-11-21 11:17 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0000917520
Ticker
IART
EIN
510317849
CUSIP
457985208
Record ID
sx:sec:0000917520

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

28 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-10SEC EDGAR company profile2026-11-21 11:17 UTCReport an error
SIC industry3841 Surgical & Medical Instruments & Apparatus2026-11-10SEC EDGAR company profile2026-11-21 11:17 UTCReport an error
State of incorporationDE2026-11-10SEC EDGAR company profile2026-11-21 11:17 UTCReport an error
Fiscal year end (MMDD)12312026-11-10SEC EDGAR company profile2026-11-21 11:17 UTCReport an error
Business address1100 CAMPUS ROAD, PRINCETON, NJ, 085402026-11-10SEC EDGAR company profile2026-11-21 11:17 UTCReport an error
ExchangesNasdaq2026-11-10SEC EDGAR company profile2026-11-21 11:17 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$1,635,245,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:17 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-516,474,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-21 11:17 UTCReport an error
Total assets (at 2025-12-31)$3,602,001,0002025-12-3110-K, XBRL Assets2026-11-21 11:17 UTCReport an error
Stockholders' equity (at 2025-12-31)$1,043,463,0002025-12-3110-K, XBRL StockholdersEquity2026-11-21 11:17 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$235,048,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:17 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$50,384,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:17 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$81,436,0002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 11:17 UTCReport an error
Long-term debt (at 2025-12-31)$726,563,0002025-12-3110-K, XBRL LongTermDebt2026-11-21 11:17 UTCReport an error
Operating lease liabilities (at 2025-12-31)$177,078,0002025-12-3110-K, XBRL OperatingLeaseLiability2026-11-21 11:17 UTCReport an error
8-K Item 2.02, RESULTS OF OPERATIONS AND FINANCIAL CONDITION (filed 2026-10-21)On October 21, 2026, Integra LifeSciences Holdings Corporation (the “Company”) issued a press release announcing financial results for the quarter ended September 30, 2026 (the “Press Release”). A copy of the Press Release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item. In the financial statements portion of the Press Release, the Company has included a reconciliation of GAAP revenues to organic revenues for the quarters ended September 30, 2026 and 2025, GAAP net income to adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the quarters ended September 30, 2026 and 2025, GAAP net income to…2026-10-21SEC EDGAR 8-K 0000917520-26-000073 (text as filed, excerpt)2026-11-21 11:17 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-02)Preliminary Unaudited Results for the Third Quarter On October 2, 2026, Integra LifeSciences Holdings Corporation (the “Company”) announced certain preliminary unaudited results for the third quarter ended September 30, 2026. The Company expects its reported revenue to be between $410 million to $412 million, reflecting an estimated $7 million impact of flooding-related supply disruptions on the Company’s manufacturing facility in Cincinnati, Ohio (the “Cincinnati facility”). The Company expects its adjusted earnings per diluted share for the third quarter to be between $0.55 to $0.59. In addition, the Company expects operating cashflow to be greater than $85 million in the third quarter.…2026-10-02SEC EDGAR 8-K 0000917520-26-000067 (text as filed, excerpt)2026-11-21 11:17 UTCReport an error
8-K Item 7.01, Regulation FD Disclosure (filed 2026-10-02)On October 2, 2026, the Company issued a press release that announced certain preliminary unaudited results for the third quarter ended September 30, 2026 and provided an update on the Company’s Cincinnati facility. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of such section, nor shall it be deemed incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act…2026-10-02SEC EDGAR 8-K 0000917520-26-000067 (text as filed, excerpt)2026-11-21 11:17 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$191,886,4882026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #2 (13F as filed): Rubric Capital Management LP$139,260,6552026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #3 (13F as filed): Invesco Ltd.$67,338,6312026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #4 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC$67,225,9502026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #5 (13F as filed): PARADIGM CAPITAL MANAGEMENT INC/NY$61,766,2002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #6 (13F as filed): FULLER & THALER ASSET MANAGEMENT, INC.$61,710,6642026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #7 (13F as filed): STATE STREET CORP$52,925,6422026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #8 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$52,913,2672026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #9 (13F as filed): NEUBERGER BERMAN GROUP LLC$42,626,5332026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error
Largest institutional holder #10 (13F as filed): DIMENSIONAL FUND ADVISORS LP$39,814,5172026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:17 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.